Finally Bristol Myers Squib receives approval from EU for Idecabtagene Vicleucel... May 23
CABENUVA reduces treatment dosing days from 365 to 12 per year ... Mar 21
Concord,a Lupin alliance partner gets another approval... Dec 20
-Advertisements-